Tower Research Capital LLC (Trc) Exact Sciences Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Exact Sciences Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,104 shares of EXAS stock, worth $68,105. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,104
Previous 34,974
96.84%
Holding current value
$68,105
Previous $1.48 Million
94.92%
% of portfolio
0.0%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.1 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$977 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$884 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$744 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$412 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...